Cite
Nebulized enriched heparin improves respiratory parameters in patients with COVID-19: a phase I/II randomized and triple-blind clinical trial
MLA
Vinicius Tadeu Ramos da Silva Grillo, et al. “Nebulized Enriched Heparin Improves Respiratory Parameters in Patients with COVID-19: A Phase I/II Randomized and Triple-Blind Clinical Trial.” Scientific Reports, vol. 14, no. 1, Aug. 2024, pp. 1–12. EBSCOhost, https://doi.org/10.1038/s41598-024-70064-8.
APA
Vinicius Tadeu Ramos da Silva Grillo, Matheus Bertanha, Lenize da Silva Rodrigues, Marcelo Andrade de Lima, Pedro Luciano Mellucci Filho, Rafael Rahal Guaragna Machado, Edson Luiz Durigon, Nathália Dias Sertorio, Marjorie de Assis Golim, Andrei Moroz, Aline Márcia Marques Braz, Leonardo Nazário de Moraes, Marco Antonio Leite, Helena Bonciani Nader, Gustavo Constantino de Campos, Cristiane Rodrigues Guzzo Carvalho, Fábio Florença Cardoso, Angelo José Magro, Helga Caputo Nunes, … Carlos Magno Castelo Branco Fortaleza. (2024). Nebulized enriched heparin improves respiratory parameters in patients with COVID-19: a phase I/II randomized and triple-blind clinical trial. Scientific Reports, 14(1), 1–12. https://doi.org/10.1038/s41598-024-70064-8
Chicago
Vinicius Tadeu Ramos da Silva Grillo, Matheus Bertanha, Lenize da Silva Rodrigues, Marcelo Andrade de Lima, Pedro Luciano Mellucci Filho, Rafael Rahal Guaragna Machado, Edson Luiz Durigon, et al. 2024. “Nebulized Enriched Heparin Improves Respiratory Parameters in Patients with COVID-19: A Phase I/II Randomized and Triple-Blind Clinical Trial.” Scientific Reports 14 (1): 1–12. doi:10.1038/s41598-024-70064-8.